Earth Science Tech, INC. (ETST) — SEC Filings

Overview

Earth Science Tech, INC. (ETST) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 24, 2026: Earth Science Tech, Inc. filed an 8-K on March 24, 2026, under Item 7.01, Regulation FD Disclosure, and Item 9.01, Financial Statements and Exhibits. This filing indicates the company is disclosing material non-public information, likely through an exhibit, which could impact its stock price. Invest

Sentiment Summary

Across 31 filings, the sentiment breakdown is: 3 bearish, 27 neutral, 1 mixed. The dominant filing sentiment for Earth Science Tech, INC. is neutral.

Filing Type Overview

Earth Science Tech, INC. (ETST) has filed 21 8-K, 6 10-Q, 2 10-K, 1 10-Q/A, 1 10-K/A with the SEC between Jan 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (31)

• Earth Science Tech Files 8-K: Regulation FD Disclosure — 8-K · Mar 24, 2026
  Earth Science Tech, Inc. filed an 8-K on March 24, 2026, under Item 7.01, Regulation FD Disclosure, and Item 9.01, Financial Statements and Exhibits. This filin
• ETST Revenue Up, Net Income Down Amidst Strategic Acquisitions — 10-Q · Nov 12, 2025 Risk: medium
  Earth Science Tech, Inc. (ETST) reported a mixed financial performance for the six months ended September 30, 2025. Total revenue increased to $17,810,816, up f
• Earth Science Tech Files 8-K for Bylaws and Financials — 8-K · Oct 14, 2025 Risk: low
  Earth Science Tech, Inc. filed an 8-K on October 14, 2025, reporting events as of August 25, 2025. The filing primarily concerns amendments to its Articles of I
• Earth Science Tech Files 8-K — 8-K · Aug 19, 2025 Risk: low
  Earth Science Tech, Inc. filed an 8-K on August 19, 2025, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not con
• ETST Revenue Plummets 99.9%, Net Loss Doubles Amid Business Shift — 10-Q · Aug 8, 2025 Risk: high
  Earth Science Tech, Inc. (ETST) reported a significant decline in revenue and an increased net loss for the quarter ended June 30, 2025. Total revenue plummeted
• Earth Science Tech Files 8-K — 8-K · Jul 1, 2025 Risk: low
  Earth Science Tech, Inc. filed an 8-K on July 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, previously known
• ETST Revenue Plunges 99.9% to $1,000 Amidst Pharmaceutical Sales Halt — 10-K · Jun 27, 2025 Risk: high
  Earth Science Tech, Inc. (ETST) reported a significant decline in revenue for the fiscal year ended March 31, 2025, with total revenue plummeting to $1,000 from
• Earth Science Tech Files 8-K — 8-K · May 6, 2025 Risk: low
  Earth Science Tech, Inc. filed an 8-K on May 6, 2025, to report on Regulation FD disclosures and financial statements. The company, previously known as Ultimate
• Earth Science Tech Files 8-K on Asset Deal & Accountant Change — 8-K · Apr 7, 2025 Risk: medium
  Earth Science Tech, Inc. filed an 8-K on April 7, 2025, reporting events as of April 1, 2025. The filing indicates a completion of an acquisition or disposition
• Earth Science Tech Reports Officer/Director Changes & Financials — 8-K · Mar 19, 2025 Risk: medium
  Earth Science Tech, Inc. filed an 8-K on March 19, 2025, reporting events as of March 11, 2025. The filing indicates changes related to the departure of directo
• Earth Science Tech Enters Material Definitive Agreement — 8-K · Mar 11, 2025 Risk: medium
  Earth Science Tech, Inc. entered into a material definitive agreement on March 7, 2025. The company, previously known as Ultimate Novelty Sports Inc., is incorp
• Earth Science Tech Files Amended Q3 2024 10-Q — 10-Q/A · Feb 18, 2025 Risk: low
  Earth Science Tech, Inc. filed an amended 10-Q for the period ending December 31, 2024. The filing, dated February 18, 2025, provides updated financial informat
• Earth Science Tech Files Q3 2025 10-Q — 10-Q · Feb 14, 2025 Risk: medium
  Earth Science Tech, Inc. filed its quarterly report for the period ending December 31, 2024. The company, formerly known as Ultimate Novelty Sports Inc., is bas
• Earth Science Tech Files 8-K: Material Agreement & Financials — 8-K · Feb 4, 2025 Risk: medium
  Earth Science Tech, Inc. entered into a Material Definitive Agreement on January 30, 2025. The company also reported other events and filed financial statements
• Earth Science Tech Appoints New CMO, Director — 8-K · Dec 30, 2024 Risk: medium
  Earth Science Tech, Inc. announced on December 26, 2024, the appointment of Dr. Steven R. Schram as Chief Medical Officer and the election of Mr. David M. Schra
• Earth Science Tech Completes 03 Life Sciences Asset Acquisition — 8-K · Dec 12, 2024 Risk: medium
  Earth Science Tech, Inc. announced the completion of its acquisition of assets from 03 Life Sciences on December 12, 2024. The company, formerly known as Ultima
• Earth Science Tech Files Q2 2025 10-Q — 10-Q · Nov 14, 2024 Risk: medium
  Earth Science Tech, Inc. filed its 10-Q for the period ending September 30, 2024. The company, previously known as Ultimate Novelty Sports Inc., is based in Mia
• Earth Science Tech Completes Asset Acquisition — 8-K · Oct 7, 2024 Risk: medium
  Earth Science Tech, Inc. (ETST) announced the completion of its acquisition of assets from a private company on October 1, 2024. The filing details the transact
• Earth Science Tech Appoints New CMO, Adds Directors — 8-K · Aug 27, 2024 Risk: medium
  Earth Science Tech, Inc. announced on August 16, 2024, the appointment of Dr. Steven R. Smith as Chief Medical Officer and the election of Dr. Smith and Mr. Rob
• Earth Science Tech, Inc. Files Q2 2024 10-Q — 10-Q · Jul 29, 2024 Risk: low
  Earth Science Tech, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Ultimate Novelty Sports Inc., is incorporated in Nev
• Earth Science Tech Files 2024 10-K — 10-K · Jun 28, 2024 Risk: medium
  Earth Science Tech, Inc. filed its 10-K for the fiscal year ending March 31, 2024, reporting on its operations as a pharmaceutical preparations company. The fil
• Earth Science Tech Files 8-K — 8-K · Jun 5, 2024 Risk: low
  Earth Science Tech, Inc. filed an 8-K on June 5, 2024, reporting an "Other Event" and "Financial Statements and Exhibits" as of June 3, 2024. The filing details
• Earth Science Tech Files 8-K — 8-K · Apr 29, 2024 Risk: medium
  Earth Science Tech, Inc. filed an 8-K on April 29, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Earth Science Tech Appoints New CMO and Directors — 8-K · Apr 19, 2024 Risk: medium
  Earth Science Tech, Inc. announced on April 16, 2024, the appointment of Dr. Steven R. Schram as Chief Medical Officer and the election of Dr. Schram and Ms. Ma
• Earth Science Tech Announces Board & Compensation Changes — 8-K · Apr 15, 2024 Risk: medium
  Earth Science Tech, Inc. announced on April 9, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departur
• Earth Science Tech Appoints New CMO, Directors — 8-K · Mar 5, 2024 Risk: medium
  Earth Science Tech, Inc. announced on March 4, 2024, the appointment of Dr. Steven R. Schram as Chief Medical Officer and the election of Dr. Schram and Mr. Rob
• Earth Science Tech, Inc. Files 10-K/A Amendment — 10-K/A · Feb 27, 2024 Risk: low
  Earth Science Tech, Inc. (ETST) filed a Amended Annual Report (10-K/A) with the SEC on February 27, 2024. Filing is an amendment to the 10-K for the fiscal year
• Earth Science Tech Discloses Non-Reliance on Past Financials — 8-K · Feb 21, 2024 Risk: high
  Earth Science Tech, Inc. (ESTI) filed an 8-K on February 21, 2024, indicating non-reliance on previously issued financial statements or a related audit report.
• Earth Science Tech, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 20, 2024 Risk: low
  Earth Science Tech, Inc. (ETST) filed a Quarterly Report (10-Q) with the SEC on February 20, 2024. Earth Science Tech, Inc. filed a 10-Q for the period ending D
• Earth Science Tech Updates Business Address & Phone Number — 8-K · Jan 29, 2024
  Earth Science Tech, Inc. (ETST) filed an 8-K on January 29, 2024, to update its business address to 8950 SW 74th CT Suite 101, Miami, FL 33156, USA, and its tel
• Earth Science Tech Updates Business Address in Florida — 8-K · Jan 9, 2024
  Earth Science Tech, Inc. (ETST) filed an 8-K on January 9, 2024, to update its business address from 10650 NW 29th Terrace Doral, FL 33172 to 8950 SW 74th CT Su

Risk Profile

Risk Assessment: Of ETST's 28 recent filings, 3 were flagged as high-risk, 16 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Earth Science Tech, INC.'s most recent 10-Q filing (Nov 12, 2025):

• Revenue: $17.81M
• Net Income: $1.43M
• Cash Position: $1.24M

Key Executives

• Dr. Steven R. Schram
• Mr. David M. Schram
• Dr. Steven R. Smith
• Mr. Robert L. Johnson
• Ms. Maria L. Latorre

Industry Context

Earth Science Tech, Inc. operates in sectors that may include health and wellness, potentially involving consumer products or specialized ingredients. The industry is characterized by evolving consumer preferences, competition from both established players and emerging brands, and increasing scrutiny regarding product efficacy and safety. Innovation and effective marketing are key differentiators.

Top Tags

financials (8) · 10-Q (5) · pharmaceuticals (5) · disclosure (4) · 8-K (4) · board-election (4) · management-change (4) · Pharmaceuticals (3) · filing (3) · acquisition (3)

Key Numbers

• Total Revenue: $17.81M — Increased by 4.2% for the six months ended September 30, 2025, from $17.09M in 2024.
• Net Income attributed to shareholders: $1.43M — Decreased by 23.7% for the six months ended September 30, 2025, from $1.87M in 2024.
• Advertising & marketing expenses: $1.37M — Increased significantly from $363,966 for the six months ended September 30, 2024.
• Depreciation and Amortization: $220,961 — Increased from $63,423 for the six months ended September 30, 2024.
• Equity Investments at fair value: $989,765 — Increased from $645,438 as of March 31, 2025.
• Cash and cash equivalents: $1.24M — Decreased by $237,854 from $1.47M at the beginning of the period.
• Purchases of property and equipment and intangibles: $584,015 — Cash outflow for investing activities for the six months ended September 30, 2025.
• Cash used for asset acquisitions: $591,265 — Cash outflow for investing activities for the six months ended September 30, 2025.
• Common shares outstanding: $292,407,607 — As of October 29, 2025.
• Preferred shares outstanding: $1,000,000 — As of October 29, 2025.
• Net Loss: $1,000,000 — for the quarter ended June 30, 2025, a 100% increase from prior year
• Pharmaceutical Products (Rx Compound) Revenue: $999,000 — for the quarter ended June 30, 2024, now $0 in 2025
• Customer Concentration: 100% — one customer accounted for all revenue in Q2 2025
• Revenue Decrease: 99.9% — percentage decrease in total revenue from Q2 2024 to Q2 2025
• Prior Year Total Revenue: $1,000,000 — Total revenue for fiscal year ended March 31, 2024.

Related Companies

ESTI · EARS

Frequently Asked Questions